Feasibility of a Physical Therapy Intervention on Older Adults With Hyperkyphosis or Forward Head Posture

Completed · Not applicable

Conditions studied: Pneumonia, COPD, Hyperkyphosis, Postural, Thoracic Kyphosis

In brief

The original intent was to use a manual therapy and therapeutic exercise intervention with older patients with pneumonia post-hospitalization. It was hypothesized that the physical therapy intervention would have a positive impact on posture, physical function, pulmonary function, gait, quality of life, and ultimately readmission. This patient population was found to be not feasible to recruit and the study target population was expanded to include older community dwelling adults with pneumonia, chronic obstructive pulmonary disease (COPD), or hyperkyphosis.

Key facts

Study ID

NCT04114331

Run by

The University of Texas Medical Branch, Galveston

People needed

24

Starts

2018-02-26

Expected to finish

2019-12-20

Last updated by the study team

2020-02-05

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• at least 50 years of age
• hyperkyphosis, forward head posture, pneumonia, or chronic obstructive pulmonary disease (COPD)
• community dwelling
• self report of ability to walk 10 feet or greater with or without an assistive device
• ability to perform informed consent
• ability to transport to research facility
• ability to read and write in English or Spanish

You may not qualify if…

• Inability to perform informed consent
• Inability to follow directions
• Inability to perform transfers, sit, and stand independently
• Inability to ambulate 10 feet or more with or without an assistive device
• Inability to perform pulmonary function testing
• Inability to fully participate in testing and measures
• Inability to fully participate in the intervention
• Severe claustrophobia
• Unable to tolerate physical touch
• Morbid obesity (BMI greater than 40)
• History of prior lung disease such as cancer or transplant
• History of comorbidity that would affect lung function such as neuromuscular disease (ALS, MS), collagen disease (SLE), cardiovascular disease (CHF), or musculoskeletal disease with an autoimmune component (Ankylosing Spondylosis, RA).
• A prior discharge within 30 days of hospitalization for pneumonia or COPD
• Discharge against medical advice

Where it is running

• School of Health Professions at the University of Texas Medical Branch — Galveston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.